Adipotide (FTPP) 5mg / 10mg peptides powder
GMP ISO TDS 18 Inquiries
62568-57-4
Pharmaceutical Grade
99.69%
1
Million
1g 10g 100g 1kg/bag 25kg/Cardboard Drum
2025-04-20
Avanafil,Tirzepatide,Semaglutide,Pregabalin,Nootropics,MT2
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceA nonapeptide that is found in neurons, peripheral organs, and plasma. This neuropeptide induces mainly delta sleep in mammals. In addition to sleep, the peptide has been observed to affect electrophysiological activity, neurotransmitter levels in the brain, circadian and locomotor patterns, hormonal levels, psychological performance, and the activity of neuropharmacological drugs including their withdrawal.Certificates
-
TDS
Basic Info-
Product Name:
Dsip
CAS No.:62568-57-4
Molecular Formula:C35H48N10O15
InChIKeys:ZRZROXNBKJAOKB-GFVHOAGBSA-N
Molecular Weight:848.8
Exact Mass:848.33006086
UNII:YN28Z5YZ73
Categories:
Research-
Class:
Chimeric peptidomimetic (fat-targeting vascular disruptor)
Status:Research compound — Not FDA approved, clinical development discontinued
Mechanism:A synthetic chimeric peptide composed of a fat-vascular-targeting cyclic peptide (CKGGRAKDC) linked via a GG spacer to a pro-apoptotic peptide (KLAKLAK)2. Adipotide selectively binds prohibitin in the vasculature of white adipose tissue, then delivers the pro-apoptotic domain to induce vascular disruption, causing fat tissue death. In primate studies (2011), it produced significant weight loss (~11%) but also caused renal toxicity, leading to development discontinuation.
Activity note:Adipotide is not a receptor agonist. It functions as a targeted vascular disruptor. Functional activity is measured by tissue-specific apoptosis, not traditional EC50.
Source:PubChem: Adipotide (CID 163360068); Kolonin MG, et al. Sci Transl Med. 2004;6(148):148ra16.DOI
References-
PubChem:Literature:
Sci Transl Med: Kolonin MG, et al. (2004) — Adipotide mechanism; ChemicalBook: Adipotide (CAS 859216-15-2)
Disclaimer:Adipotide is NOT FDA-approved or EMA-approved. It is a research compound only. Clinical development was discontinued due to renal toxicity observed in primate studies. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Avanafil,Tirzepatide,Semaglutide,Pregabalin,Nootropics,MT2
-
Location:
Room 1-2208, Lianhecaifu Square, No2177, Tianchen Road, Gaoxin District, Jinan City, Shandong Province, China
-
Payment Terms:
L/C,100% TT in advance
-
Average lead Time:
3
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2012
-
Certifications:
business license
-
-
Inquiry History18 Inquiries
Country Product Purchase Quantity Date Posted
Germany
Dsip
1 MT Apr 26, 2026
United States
DSIP
10 MT Mar 12, 2026
United States
DSIP
10 MG Jan 12, 2026
United States
DSIP
1 G Nov 10, 2025
United States
dsip
1 Oct 20, 2025
United States
DSIP lyphilized powder
100 MG Jun 24, 2025
United States
Adipotide 5mg 10vial kit
1 MT Feb 25, 2024
United Kingdom
Dsip
10 MG Jun 17, 2026
United States
Dsip
10 G Jan 12, 2026
United States
dsip
100 G May 17, 2026
United States
DSIP
10 MT Apr 27, 2026
United States
DSIP
10 Apr 13, 2026
United States
DSIP
1 MT Apr 10, 2026
United States
Dsip
100 MT Feb 3, 2026
United States
Dsip
1 MT Dec 17, 2025
Italy
Adipotide
100 MG Jun 2, 2024
United States
DSIP
100 MG Nov 28, 2025
United States
Epitalon, NAD+, DSIP, 5-Amino-1MQ, PEG-MGF
1 May 9, 2026 Post an enquiry for this product
